Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM PAR
-
Number of holders
-
19
-
Total 13F shares, excl. options
-
768,087
-
Shares change
-
+109,537
-
Total reported value, excl. options
-
$6,398,000
-
Value change
-
+$913,815
-
Number of buys
-
9
-
Number of sells
-
-3
-
Price
-
$8.33
Significant Holders of IMMUCELL CORP /DE/ - COM PAR (ICCC) as of Q3 2018
20 filings reported holding ICCC - IMMUCELL CORP /DE/ - COM PAR as of Q3 2018.
IMMUCELL CORP /DE/ - COM PAR (ICCC) has 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 768,087 shares
.
Largest 10 shareholders include HEARTLAND ADVISORS INC (199,600 shares), PERRITT CAPITAL MANAGEMENT INC (154,300 shares), RENAISSANCE TECHNOLOGIES LLC (96,100 shares), INGALLS & SNYDER LLC (91,511 shares), Vanguard Group Inc (71,469 shares), SHUFRO ROSE & CO LLC (50,791 shares), Essex Financial Services, Inc. (23,776 shares), Minerva Advisors LLC (14,559 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (13,187 shares), and RBF Capital, LLC (13,086 shares).
This table shows the top 19 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.